These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2463874)

  • 1. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
    Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
    Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
    Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
    Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS; Aterman K
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
    Warhol MJ; Longtine JA
    J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in biological markers in prostate cancer.
    Pontes JE
    Recent Results Cancer Res; 1990; 118():186-9. PubMed ID: 1700455
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with prostate-specific antigen in prostatic carcinoma.
    Romics I; Bach D
    Int Urol Nephrol; 1991; 23(5):465-72. PubMed ID: 1718923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
    Zhou R; Sause WT; Hammond EH; Rubin P; Perez C; Pilepich MV; Asbell SD; Parker DL
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):823-9. PubMed ID: 7591889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prostate-specific antigen in prostate cancer.
    Pons-Anicet D; Ramaioli A; Namer M; Krebs BP
    Am J Clin Oncol; 1988; 11 Suppl 2():S71-4. PubMed ID: 2468278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.
    Goldrath DE; Messing EM
    J Urol; 1989 Oct; 142(4):1082-4. PubMed ID: 2477560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crescentic glomerulonephritis associated with prostatic carcinoma: evidence of immune-mediated glomerular injury.
    Haskell LP; Fusco MJ; Wadler S; Sablay LB; Mennemeyer RP
    Am J Med; 1990 Feb; 88(2):189-92. PubMed ID: 1689105
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
    Fan K
    J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates.
    Erickson DR; Hlavinka TC; Rockwood AP; Metter JD; Novicki DE; Fried MG
    J Urol; 1991 Nov; 146(5):1402-7. PubMed ID: 1719247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of mucinous adenocarcinoma of the prostate].
    Ezura M; Kimura N; Nagura H
    Gan No Rinsho; 1990 Mar; 36(4):563-6. PubMed ID: 1690826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical detection of prostate carcinoma].
    Ma WX; Li W
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading.
    Hasenson M; Lundh B; Stege R; Carlström K; Pousette A
    Prostate; 1989; 14(2):83-90. PubMed ID: 2469074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.